InsidersTradesSigma
프레스티지바이오로직스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 프레스티지바이오로직스 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 프레스티지바이오로직스 has logged 47 reports. The latest transaction was filed on 10 July 2026 (Other). Among the most active insiders: 프레스티지바이오파마. The full history is accessible without an account.
47
Insider Decl.
0
Thresholds
·
32 ops.
Buy Volume
·
0 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 July 2026
Declarations47 total
15,916,168 sharesKRXDART:20240927000731
Ideal exit: 22 Jun 2025 (T+270)
ShareKRXDART:20240927000751
Ideal exit: 22 Jun 2025 (T+270)
ShareKRXDART:20231222000185
Ideal exit: 15 Sept 2024 (T+270)
ShareKRXDART:20231222000181
Ideal exit: 15 Sept 2024 (T+270)
15,916,168 sharesKRXDART:20231219000013
Ideal exit: 13 Sept 2024 (T+270)
15,916,168 sharesKRXDART:20231215000446
Ideal exit: 6 Sept 2024 (T+270)
ShareKRXDART:20230525000078
Ideal exit: 16 Feb 2024 (T+270)
15,916,168 sharesKRXDART:20230523000020
Ideal exit: 12 Feb 2024 (T+270)
ShareKRXDART:20230404002700
Ideal exit: 30 Dec 2023 (T+270)
15,916,168 sharesKRXDART:20230324001123
Ideal exit: 19 Dec 2023 (T+270)
15,916,168 sharesKRXDART:20230306000361
Ideal exit: 1 Dec 2023 (T+270)
15,916,168 sharesKRXDART:20221230000465
Ideal exit: 26 Sept 2023 (T+270)
15,916,168 sharesKRXDART:20221222000028
Ideal exit: 18 Sept 2023 (T+270)
ShareKRXDART:20220915000499
Ideal exit: 12 Jun 2023 (T+270)
15,916,168 sharesKRXDART:20220915000493
Ideal exit: 12 Jun 2023 (T+270)
15,916,168 sharesKRXDART:20220915000490
Ideal exit: 12 Jun 2023 (T+270)
15,916,168 sharesKRXDART:20220908000614
Ideal exit: 5 Jun 2023 (T+270)
25 of 47 declarations
About 프레스티지바이오로직스
Prestige Biologics is a company specializing in the manufacturing of biological products for the pharmaceutical industry. It is listed on the XKRX market.